| | | |   | | | | By Ed Silverman Drew Angerer/Getty Images A judge granted the SEC's request to permanently bar Martin Shkreli from serving as an officer or director of any publicly traded company. Read More | | By Ed Silverman Adobe Three years ago, a U.K. official pushed universities to start reporting clinical trial results. New research finds the pressure paid off. Read More | | By Tom Murphy — Associated Press Jim Mone/AP Federal regulators are suing to block UnitedHealth Group's purchase of the technology company Change Healthcare. Read More | | Sponsor content by SUFFOLK UNIVERSITY BOSTON Pharma at the intersection of private enterprise and public interest The pharmaceutical industry is global, highly competitive, and tightly regulated. As its challenges and opportunities grow, so does its need for professionals who fully understand the legal, business, and scientific considerations involved in the drug development process. Tomorrow's pharma leaders can gain that expertise with a Master of Science in Law: Life Sciences. | | By Adam Feuerstein Adobe The abrupt dissolution of a blank-check merger points to more trouble for the already deflated gene therapy field. Read More | |
No comments